Skip to content

Clinical study on prevention and treatment of safflower yellow to oral mucositis after radiotherapy for nasopharyngeal carcinoma

Clinical study on prevention and treatment of safflower yellow to oral mucositis after radiotherapy for nasopharyngeal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012269
Enrollment
Unknown
Registered
2017-08-06
Start date
2017-08-07
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

treatment:Safflower yellow pigment administration+routine nursing
Control group:Routine nursing

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. newly diagnosed nasopharyngeal carcinoma diagnosed by pathology, clinical stage II to IVa (2010AJCC 7th); 2. Aged from 18 to 70 years male and female; 3. no head and neck surgery history, no chemotherapy history; 4. ECOG score 0-2 points; 5. no history of toothless disease; 6. the laboratory examination before chemotherapy and radiotherapy meets the following conditions: (1) liver function: total bilirubin = 1.5 times the upper limit of normal; aspartate aminotransferase and alanine aminotransferase = 2.5 times the upper limit of normal; alkaline phosphatase = 1.5 times the upper limit of normal; (2) renal function: creatinine clearance rate = 80ml / min; (3) blood function: absolute neutrophil count = 2×10^9/L, platelet count = 100×10^9/L, hemoglobin = 9g/dL; (4) blood glucose levels: good glycemic control, fasting blood glucose 3.9-7.2mmol/L, 2 hours after the meal blood glucose = 1.0mmol/L, glycosylated hemoglobin <7%. 7. no distant evidence of the metastasis; 8. no serious heart, liver, kidney dysfunction and radiotherapy and chemotherapy taboo; 9. Enhanced CT and MRI scans of the nasopharynx and neck before treatment, and / or PET / CT scan.

Exclusion criteria

Exclusion criteria: 1. Previously had anti-tumor therapy, including radiotherapy, chemotherapy and surgery; 2. distant metastases were found before treatment; 3. has oral mucositis or oral mucositis occurred repeatedly (1 times / month or more) before chemotherapy or radiotherapy; 4. with periapical inflammation; 5. pregnant or lactating women; 6. have severe heart, liver, lung, kidney dysfunction or poor blood sugar control, can not tolerate chemotherapy and chemotherapy; 7. Patients with mental disorders.

Design outcomes

Primary

MeasureTime frame
Oral mucositis;

Countries

China

Contacts

Public ContactLijun Wang

Jiangsu Cancer Hospital

dr_wanglj@163.com+86 13645154390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026